Northern Trust Corp raised its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 2.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,423,865 shares of the company's stock after purchasing an additional 31,224 shares during the quarter. Northern Trust Corp owned approximately 1.17% of Privia Health Group worth $31,966,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of PRVA. Fox Run Management L.L.C. bought a new stake in shares of Privia Health Group during the 1st quarter worth about $277,000. Sei Investments Co. boosted its holdings in shares of Privia Health Group by 0.6% during the first quarter. Sei Investments Co. now owns 576,993 shares of the company's stock worth $12,953,000 after acquiring an additional 3,358 shares during the period. Caitong International Asset Management Co. Ltd grew its position in shares of Privia Health Group by 2,115.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company's stock valued at $75,000 after purchasing an additional 3,173 shares during the last quarter. Russell Investments Group Ltd. increased its stake in shares of Privia Health Group by 2,852.2% during the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company's stock worth $60,000 after purchasing an additional 2,567 shares during the period. Finally, Public Sector Pension Investment Board increased its stake in shares of Privia Health Group by 27.3% during the first quarter. Public Sector Pension Investment Board now owns 327,247 shares of the company's stock worth $7,347,000 after purchasing an additional 70,209 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.
Privia Health Group Stock Performance
Shares of Privia Health Group stock traded down $0.05 on Thursday, reaching $23.12. 903,034 shares of the stock were exchanged, compared to its average volume of 876,703. The firm has a market cap of $2.84 billion, a PE ratio of 210.20, a P/E/G ratio of 3.36 and a beta of 0.82. The firm's 50 day moving average is $21.01 and its 200-day moving average is $22.61. Privia Health Group, Inc. has a one year low of $16.47 and a one year high of $26.09.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The firm had revenue of $521.15 million during the quarter, compared to the consensus estimate of $466.97 million. During the same period last year, the business earned $0.19 earnings per share. The business's revenue was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS. On average, equities research analysts expect that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the company. Evercore ISI reduced their price target on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating for the company in a research note on Wednesday, July 9th. Zacks Research raised Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 19th. JMP Securities boosted their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "market outperform" rating in a research report on Friday, August 29th. Citigroup restated an "outperform" rating on shares of Privia Health Group in a research note on Friday, August 29th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $28.58.
Read Our Latest Report on PRVA
About Privia Health Group
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Read More

Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.